2 recruiting. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Peanut Oral Immunotherapy (OIT): new trials by email Literature Review of Peanut Oral Immunotherapy (OIT) trials Research Report on Peanut Oral Immunotherapy (OIT)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Tezepelumab in Peanut Oral Immunotherapy Tezepelumab, Peanut Oral Immunotherapy (OIT), Placebo for Tezepelumab - Peanut Allergy | Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 62 | 2026-07-27 | 2026-10-22 |
| Pathway to Peanut Tolerance Peanut Oral Immunotherapy (OIT) - Food Allergy in Children, Food Allergy Peanut | Not applicable | Recruiting | Chinese University of Hong Kong | 125 | 2025-11-15 | 2026-05-19 |
Peanut Hypersensitivity (2) · Food Hypersensitivity (1)
Chinese University of Hong Kong (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Hong Kong (1) · United States (1)
Edwin H Kim, M.D., M.S. (1) · Sarita Patil, M.D. (1)